Market Place
Sourcing Support
Gracell to Present Data Highlighting Efficacy of SMART CART Against Solid Tumors
31 Oct 2023 //
GLOBENEWSWIRE
Gracell to Report Third Quarter 2023 Financials on Monday, November 13, 2023
30 Oct 2023 //
GLOBENEWSWIRE
Gracell CEO Dr. William Cao Named to Prestigious PharmaVoice 100
19 Sep 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in BTIG Virtual Biotechnology Conference
31 Jul 2023 //
GLOBENEWSWIRE
Gracell to Report Second Quarter 2023 Financials on Monday, August 14, 2023
31 Jul 2023 //
GLOBENEWSWIRE
Gracell Reports Fourth Quarter and Full Year 2022 Financial Results
13 Mar 2023 //
GLOBENEWSWIRE
Gracell receives FDA clearance for multiple myeloma therapy trial
06 Feb 2023 //
CLINICAL TRIALS ARENA
Gracell Biotechnologies Reports 3Q 2022 Unaudited Financial Results
14 Nov 2022 //
GLOBENEWSWIRE
Gracell to Present Data of FasTCAR-T GC012F for Newly Diagnosed Multiple Myeloma
03 Nov 2022 //
PRNEWSWIRE
Gracell Biotechnologies Reports Second Quarter 2022 Unaudited Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Gracell Biotechnologies Appoints Wendy Li as CMO
01 Aug 2022 //
PRNEWSWIRE
Gracell Bio Appoints Veteran BioPharma Executive Dr. Samuel Zhang as CBO
19 Jul 2022 //
PRNEWSWIRE
Gracell Biotechnologies Reports First Quarter 2022 Unaudited Financial Results
16 May 2022 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Three Investor Conferences in May
04 May 2022 //
GLOBENEWSWIRE
Gracell Biotechnologies Announces Filing of Its Annual Report on Form 20-F
22 Apr 2022 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Three Investor Conferences in April
29 Mar 2022 //
GLOBENEWSWIRE
Gracell Bio Reports Q4 and Full Year 2021 Unaudited Financial Results
14 Mar 2022 //
GLOBENEWSWIRE
Gracell Bio to Participate in Oppenheimer 32nd Annual Healthcare Conference
10 Mar 2022 //
GLOBENEWSWIRE
Gracell Bio to Report Q4 & Full Year 2021 Financial Results on March 14
02 Mar 2022 //
GLOBENEWSWIRE
Gracell Bio Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform
22 Feb 2022 //
PRNEWSWIRE
Gracell Cell Therapy for Multiple Myeloma Granted FDA ODD
16 Jan 2022 //
TRIALSITENEWS
Gracell Biotech to open newly established Innovation Center in US
14 Jan 2022 //
PHARMABIZ
Gracell Biotechnologies Unveils Innovation Center in U.S.
12 Jan 2022 //
PRNEWSWIRE
Gracell Biotechnologies Announces Senior Management Team Share Purchase Plan
23 Nov 2021 //
PRNEWSWIRE
Gracell Granted FDA ODD to GC012F for Multiple Myeloma
19 Nov 2021 //
PRNEWSWIRE
Gracell Biotechnologies to Participate in Piper Sandler 33rd Annual VHC
17 Nov 2021 //
GLOBENEWSWIRE
Gracell Biotechnologies to Present Preclinical Results of TruUCAR- CD19/CD7
04 Nov 2021 //
PRNEWSWIRE
Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results
17 Aug 2021 //
GLOBENEWSWIRE
Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results
17 Aug 2021 //
GLOBENEWSWIRE
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen
16 Aug 2021 //
PR NEWSWIRE
Gracell Participate Fireside Chat at the BTIG Virtual Biotechnology Conference
26 Jul 2021 //
GLOBENEWSWIRE
Gracell Biotechnologies Hosting Key Opinion Leader Webinar on High Risk
26 May 2021 //
PRNEWSWIRE
Gracell Biotechnologies Hosting Key Opinion Leader Webinar on High Risk
26 May 2021 //
PRNASIA
Gracell Biotechnologies to Present Results of GC012F FasTCAR-enabled BCMA/CD19
18 May 2021 //
PRNEWSWIRE
Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive
11 May 2021 //
PRNASIA
Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive
10 May 2021 //
PRNASIA
Gracell Bio leverages Lonza`s expertise in CAR-T cell therapy manufacturing
01 Apr 2021 //
BIOSPECTRUMASIA
Gracell Biotechnologies Signs Agreement with Lonza to Manufacture Gracell`s
31 Mar 2021 //
PRNASIA
Gracell Receives IND Approval from China NMPA for GC019F
20 Jan 2021 //
PRNASIA
Gracell Biotechnologies Receives IND Approval from China NMPA for GC019F
19 Jan 2021 //
PRNEWSWIRE
Gracell Biotechnologies Receives IND Approval from China NMPA for GC019F
18 Jan 2021 //
PRNEWSWIRE
Gracell Biotechnologies Receives Medical Products Manufacturing Certificate
15 Jan 2021 //
PRNASIA
Gracell Receives Medical Products Manufacturing Certificate for CAR-T Cell
15 Jan 2021 //
PRNEWSWIRE
Gracell Biotechnologies gets China NMPA approval for phase 1/2 study
14 Jan 2021 //
PHARMABIZ
Gracell Biotechnologies Announces Pricing of Initial Public Offering
08 Jan 2021 //
PRNEWSWIRE
Chinese cancer biotech Gracell Biotechnologies files for a $100 million US IPO
18 Dec 2020 //
RENAISSANCECAPITAL
Chinese cancer biotech Gracell Biotechnologies files for a $100 million US IPO
18 Dec 2020 //
RENAISSANCECAPITAL
Gracell Announces Two Presentations at the Annual Meeting of (ASCO)
29 May 2020 //
PRNEWSWIRE
Gracell Reports Data of First-in-human Trial for Universal TruUCAR™ GC027
28 Apr 2020 //
PR NEWSWIRE
Gracell to Present the First-in-human, Universal TruUCAR™ GC027 Therapy
13 Apr 2020 //
PRNEWSWIRE
